Giant Abdominal Wall Desmoid Tumor with Mass Effect: A Case Report and Review of the Literature
Main Article Content
Abstract
Desmoid tumors, or aggressive fibromatoses, are rare fibroblastic proliferations of soft tissues. Although benign from a metastatic standpoint, they possess a high potential for local invasion. Giant forms, inducing a compressive mass effect, pose complex therapeutic challenges. This case report highlights the critical decision-making process in giant abdominal wall desmoid tumors where immediate salvage surgery takes precedence over conservative active surveillance due to severe symptoms and tissue compression. We report the case of a 46-year-old female patient presenting with a large mass on the abdominal wall evolving over 6 months, causing chronic pain, functional impairment, and a significant mass effect on adjacent pelvic structures. Magnetic resonance imaging (MRI) revealed a large infiltrating tissue lesion. Biopsy and immunohistochemistry confirmed the diagnosis of aggressive fibromatosis. Given the significant mass effect, wide surgical excision with tumor-free margins was performed. The postoperative course was uneventful, with no local recurrence at the 6-month follow-up.
Conclusion: The management of giant desmoid tumors with mass effect requires a personalized, multidisciplinary approach, oscillating between monitoring, medical alternatives, and salvage surgery.
Downloads
Article Details
Copyright (c) 2026 Sihem D, et al.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Desmoid Tumor Working Group. The management of desmoid tumors: A joint global consensus-based guideline approach for adult and pediatric patients.Eur J Cancer2020;127:96-107. Available from: https://doi.org/10.1016/j.ejca.2019.11.013 DOI: https://doi.org/10.1016/j.ejca.2019.11.013
Kasper B, Baumgarten C, Garcia J, Bonvalot S, Hoekstra HJ. An update on the management of desmoid-type fibromatosis: On behalf of the European Organization for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group.Eur J Cancer2017;80:89-98. Available from: https://doi.org/10.1093/annonc/mdx323 DOI: https://doi.org/10.1093/annonc/mdx323
Penel N, Chibon F, Salas S. Management of desmoid tumors: A large national retrospective study of 771 patients by the French Sarcoma Group.Ann Oncol2019;30(2):241-248.
Bassan F, Dupuis O, Lardy H. Management of desmoid tumors: Paradigm change and new recommendations.J Chir Visc2020;157(4):285-292.
Salas S, Kaur A, Liang X, Blay JY. Abdominal wall desmoid tumors: Surgical outcomes and risk of recurrence in a cohort of 142 patients.World J Surg2018;42(9):2810-2818.